Skip to main content

Xianku

ServiceShenzhen, ChinaFounded 2016· One of 1986 Service companies tracked by AMPulse

Develops a full-stack 3D body scanning and AI diagnostic platform that automates the production of custom 3D-printed orthopedic insoles and footwear.

CEO / Founder
Yuan Zhuang (袁壮)
Team Size
51-200
Stage
Active
Total Funding
$4.5M
Latest Round
Pre-Series A
Key Investors
Cowin Capital (同创伟业); Shenzhen Angel FOF (深圳天使母基金)

Technology & Products

Key Products

3D Intelligent Body Measurement Mirror; 3D Intelligent Foot Scanner; AI Health Diagnosis Cloud Platform; 3D-Printed Orthopedic Insoles; Customized 3D-Printed Footwear

Technological Advantage

The AI diagnostic engine eliminates the need for manual CAD design for each patient, allowing for mass customization of medical-grade insoles at a scale and speed unattainable by traditional manufacturing or manual 3D modeling.

Differentiation

Value Proposition

Reduces the lead time for custom orthopedic footwear from weeks to days by replacing manual casting with millimeter-precision 3D scanning and automated 3D printing, improving patient fit and clinical outcomes while reducing inventory costs for retailers.

How They Differentiate

Unlike pure scanning companies like SHINING 3D, Xianku provides the end-to-end application layer (AI diagnosis + 3D printed product); compared to LuxCreo, Xianku focuses more heavily on the medical diagnostic data collection (spine and foot health) rather than just the printing process.

Market & Competition

Target Customers

Hospitals, orthopedic clinics, high-end footwear retailers, and health management centers.

Industry Verticals

Medical; Consumer Retail; Sports Science; Health & Wellness

Competitors

LuxCreo; Volumental; SHINING 3D; FitMyFoot

Growth & Milestones

Growth Metrics

Raised tens of millions of RMB in Pre-A round (2021); expanded product line from foot scanning to full-body spine analysis and 3D-printed consumer goods.

Major Milestones

2016: Company founded in Shenzhen; 2019: Launched first-generation 3D intelligent body mirror; 2021: Completed Pre-A funding round led by Cowin Capital; 2023: Established full-stack 3D-printed insole production line; 2025: Obtained Class II medical device production permit, expanded into AI hardware sales; 2026: Launched 3D Intelligent Foot-Spine Scanner XK-CH005

Notable Customers

Major Chinese Orthopedic Hospitals; Premium Sports Retailers; Health Management Groups

https://xianku.com

Why this company matters

Shenzhen Xianku Intelligent Co., Ltd. occupies a challenger position in the custom orthopedic footwear market by combining 3D body scanning hardware with an AI diagnostic platform that directly drives polymer 3D printing. Its closed-loop 'Scan-to-Print' system eliminates manual CAD modeling, reducing lead time from weeks to days while improving fit consistency and lowering inventory costs for retailers.

The company's core technology stack integrates millimeter-precision 3D foot and body scanners with an AI health diagnosis cloud platform that automatically generates production-ready 3D files for orthopedic insoles and custom footwear. Production relies on polymer powder bed fusion (PBF-LB) and vat photopolymerization (VPP-DLP) processes, enabling mass customization of medical-grade insoles at a scale unattainable through traditional manual methods.

Xianku serves hospitals, orthopedic clinics, premium footwear retailers, and health management centers in China. Its product line includes the 3D Intelligent Body Measurement Mirror, 3D Intelligent Foot Scanner, AI Health Diagnosis Cloud Platform, and 3D-printed orthopedic insoles and customized footwear. Notable customers include major Chinese orthopedic hospitals and premium sports retailers.

The company differentiates from pure scanning firms like SHINING 3D by providing the end-to-end application layer of AI diagnosis plus 3D-printed product, and from printing-focused competitors like LuxCreo by emphasizing medical diagnostic data collection for spine and foot health. Key investors include Cowin Capital and Shenzhen Angel FOF, with a Pre-A round completed in 2021. The company expanded from foot scanning to full-body spine analysis and 3D-printed consumer goods by 2023.